602 related articles for article (PubMed ID: 30674010)
1. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Endocrinol Invest; 2019 Aug; 42(8):951-965. PubMed ID: 30674010
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
Vignozzi L; Morelli A; Cellai I; Filippi S; Comeglio P; Sarchielli E; Maneschi E; Vannelli GB; Adorini L; Maggi M
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):277-292. PubMed ID: 27425465
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Endocrinol Invest; 2019 Mar; 42(3):283-294. PubMed ID: 29923060
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
Ye L; Jiang Y; Zuo X
Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
[TBL] [Abstract][Full Text] [Related]
6. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of bile acid receptor agonists in pulmonary disease models.
Comeglio P; Morelli A; Adorini L; Maggi M; Vignozzi L
Expert Opin Investig Drugs; 2017 Nov; 26(11):1215-1228. PubMed ID: 28949776
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats.
Chaumais MC; Ranchoux B; Montani D; Dorfmüller P; Tu L; Lecerf F; Raymond N; Guignabert C; Price L; Simonneau G; Cohen-Kaminsky S; Humbert M; Perros F
Respir Res; 2014 Jun; 15(1):65. PubMed ID: 24929652
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
[TBL] [Abstract][Full Text] [Related]
14. Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats.
Sakamoto Y; Kameshima S; Kakuda C; Okamura Y; Kodama T; Okada M; Yamawaki H
Pflugers Arch; 2017 Nov; 469(11):1425-1432. PubMed ID: 28776262
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
18. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice.
Fei J; Fu L; Hu B; Chen YH; Zhao H; Xu DX; Li JB
Int Immunopharmacol; 2019 Jan; 66():177-184. PubMed ID: 30468885
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
Sun LY; Cai ZY; Pu J; Li J; Shen JY; Yang CD; He B
Inflammation; 2017 Jun; 40(3):806-817. PubMed ID: 28213866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
